Scientists call for EU embryo research and development consensus
This article was originally published in Clinica
Leading EU scientists have called on member states to remove political and legislative barriers to stem cell research, in the belief that differences in policy "seriously hinder [its] advancement", particularly with regard to international collaboration and sharing biomedical knowledge. Despite the common funding provided for this under the European Commission's FP-6 and FP-7 research frameworks, "scientists within Europe cannot freely exchange personnel and cell lines", said ESTOOLS consortium co-ordinator Professor Peter Andrews.
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.